<DOC>
	<DOCNO>NCT00339937</DOCNO>
	<brief_summary>A series study conduct Sicily collaborative team U.S. National Cancer Institute University Palermo well understand prevalence risk factor newly discover human herpes virus 8 ( HHV8 ) Kaposi sarcoma ( KS ) , may consequence HHV8 infection . There four short-term project : 1 . To determine HHV8 seroprevalence extant , unlinked serum informative group , include homosexual men , person sexually transmit disease , general population group , particularly elderly . In addition , HHV8 prevalence serological study may determine among adult , particularly may recruit future study likely enhance understand HHV8 serology . 2 . To identify pediatric syndrome might associate HHV8 infection , HHV8 seroprevalence determine serum hospitalize child wide range clinical condition . 3 . To determine HHV8 seroprevalence various region Italy HLA Class II group link increase ( HLA-DR5 ) decrease ( HLA-DR3 ) risk KS , use extant , unlinked serum data volunteer bone marrow donor . 4 . To conduct case control study identify risk factor KS among person infect HHV8 manifest anti-HHV8 latent antibody . The result project summarize publication medical scientific literature design prioritization related project future .</brief_summary>
	<brief_title>Studies Human Herpesvirus 8 Kaposi 's Sarcoma Sicily</brief_title>
	<detailed_description>A series study conduct Sicily collaborative team U.S. National Cancer Institute University Palermo well understand prevalence risk factor newly discover human herpes virus 8 ( HHV8 ) Kaposi sarcoma ( KS ) , may consequence HHV8 infection . There four short-term project : 1 . To determine HHV8 seroprevalence extant , unlinked serum informative group , include homosexual men , person sexually transmit disease , general population group , particularly elderly . In addition , HHV8 prevalence serological study may determine among adult , particularly may recruit future study likely enhance understand HHV8 serology . 2 . To identify pediatric syndrome might associate HHV8 infection , HHV8 seroprevalence determine serum hospitalize child wide range clinical condition . 3 . To determine HHV8 seroprevalence various region Italy HLA Class II group link increase ( HLA-DR5 ) decrease ( HLA-DR3 ) risk KS , use extant , unlinked serum data volunteer bone marrow donor . 4 . To conduct case control study identify risk factor KS among person infect HHV8 manifest anti-HHV8 latent antibody . The result project summarize publication medical scientific literature design prioritization related project future .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<criteria>Not specify .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 13, 2017</verification_date>
	<keyword>Human Herpes virus 8 ( HHV8 )</keyword>
	<keyword>Kaposi sarcoma ( KS )</keyword>
</DOC>